Figure 1.
Characterization of the Omicron vaccine candidate. (A,B) SARS-CoV-2 maximum likelihood phylogenetic tree. (C) Growth kinetic analysis of 3 Omicron strains. (D) The effect of inoculation MOI on HK-OM-P7 stock virus titer. (E) Inactivation kinetics of three batches of virus supernatant. (F) The protein composition of Omicron vaccine (Vero cell) was evaluated by incubating with antibodies targeting S1 protein, S2 protein, and N protein.